FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pharmakon Pharmaceuticals Midazolam 1 mg/mL in 0 Recall

Midazolam 1 mg/mL in 0

Pharmakon Pharmaceuticals · Noblesville, IN

Risk level
Class II
Reported by FDA
Feb 3, 2016
Recall ID
D-0603-2016
Check your lot numberHow we source this data

Summary

Pharmakon Pharmaceuticals recalled Midazolam 1 mg/mL in 0 starting Aug 19, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0603-2016 on Feb 3, 2016. Reason: Stability data does not support expiry. Status: Terminated.

Why it was recalled

Stability data does not support expiry.

Product description

Midazolam 1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 2 mg/ 2mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

Lot numbers, UPCs & expiration codes

All lots with expiration dates up to 11/17/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0603-2016
Classification
Class II
Status
Terminated
Recall initiated
Aug 19, 2015
FDA report date
Feb 3, 2016
Quantity
5000
Recall type
Voluntary: Firm initiated
Recalling firm
Pharmakon Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0603-2016, exactly as published.

Show all FDA fields
City
Noblesville
State
IN
Status
Terminated
Country
United States
Event ID
72177
Address
14450 Getz Rd
Code information
All lots with expiration dates up to 11/17/2015
Postal code
46060-3303
Report date
Feb 3, 2016
Product type
Drugs
Recall number
D-0603-2016
Classification
Class II
Recalling firm
Pharmakon Pharmaceuticals
Product quantity
5000
Termination date
May 9, 2017
Reason for recall
Stability data does not support expiry.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Midazolam 1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 2 mg/ 2mL, Rx only, PHARMAKON Pharmaceuticals, Inc.
Distribution pattern
Nationwide
Recall initiation date
Aug 19, 2015
Initial firm notification
Telephone
Center classification date
Jan 27, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0603-2016, published Feb 3, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls